RAPT - RAPT Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RAPT is currently covered by 5 analysts with an average price target of $58.83. This is a potential upside of $171.65 (1.41%) from yesterday's end of day stock price of $58.01.

RAPT Therapeutics's activity chart (see below) currently has 29 price targets and 63 ratings on display. The stock rating distribution of RAPT is 14.29% HOLD and 85.71% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72% with an average time for these price targets to be met of 344 days.

Highest price target for RAPT is $70, Lowest price target is $57, average price target is $58.83.

Most recent stock forecast was given by from LEERINK on 21-Jan-2026. First documented stock forecast 25-Nov-2019.

Currently out of the existing stock ratings of RAPT, 2 are a HOLD (14.29%), 12 are a BUY (85.71%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Jan-2026

$58

$-0.01 (-0.02%)

$37

7 months 19 days ago
(21-Jan-2026)

4/4 (100%)

$0.39 (0.68%)

395

1.54

Hold Since 21-Jan-2026

$58

$-0.01 (-0.02%)

$56

7 months 19 days ago
(21-Jan-2026)

4/4 (100%)

$0.39 (0.68%)

76

6.04

Buy Since 25-Nov-2019

$58

$-0.01 (-0.02%)

$72

7 months 20 days ago
(20-Jan-2026)

5/6 (83.33%)

$0.43 (0.75%)

692

1.21

Buy Since 28-Oct-2025

$58

$-0.01 (-0.02%)

$72

7 months 20 days ago
(20-Jan-2026)

1/2 (50%)

$0.43 (0.75%)

41

0.09

Buy Since 05-Jun-2025

$58

$-0.01 (-0.02%)

$60

7 months 20 days ago
(20-Jan-2026)

2/4 (50%)

$0.43 (0.75%)

77

1.24

Show more analysts

Please expand the browser size to see the chart

What is RAPT (RAPT Therapeutics) average time for price targets to be met?

On average it took 344 days for the stock forecasts to be reached, with an average price target met ratio of 72%.

Which analyst most recently updated their price target on RAPT (RAPT Therapeutics)?

Which analyst has the most public recommendations on RAPT (RAPT Therapeutics)?

has 0 price targets and 0 ratings on RAPT

Which analyst is the currently most bullish on RAPT (RAPT Therapeutics)?

Alethia Young with the highest potential upside of $3653.99

Which analyst is the currently most reserved on RAPT (RAPT Therapeutics)?

Eliana Merle with the lowest potential downside of -$49.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?